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Objectives.
The purpose of this study was to determine the
effects of naloxone on systemic hernodynamics and reflex function
in dogs with congestive heart failure induced by rapid pacing .
Background.
We have shown previously that naloxone, an
opiate receptor antagonist, improves cardiac output, aortic blood
pressure, systolic performance anti the baroreflex function in
conscious dogs with chronic right-sided congestive heart failure .
However, whether endogenous opiolds also play a role in mediat-
ing the reduction of myocardial and ba flex function in animals
with left heart failure remains controversial .
Metlwds . We administered naloxone (1 mg/kg body weight)
and normal saline solution to 15 dogs with pacing-induced con-
gestive heart failure (225 beats/min for 8 weeks) and 11 control
dogs. In addition to systemic hemodynarnic measurements, the
slope of pressure-area relation obtained from echocardiography
with intravenous bolas injection of phenylephrine was taken as a
load-independent index of myocardial contractility . Barorellex
function was estimated by the slope of the regression line relating
systolic aortic pressure and RR interval .
Results. Plasma beta-erdorphin levels were elevated in flags
Much evidence has accumulated that the endogenous opiate
system is activated by various forms of shock and that the
opiate antagonist naloxone reverses the hypotension and
impaired cardiac function that occur in acute shock (1-7) .
However, relatively little is known of the role of endogenous
opiates on cardiac function in chronic congestive heart
failure . Our laboratory (8,9) was the first to demonstrate that
plasma beta-endorphin levels were elevated in experimental
right-sided congestive heart failure produced by surgical
tricuspid avulsion and progressive pulmonary arterial con-
striction and that inhibition of the opiate receptors improved
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with congestive heart failure. Naloxone administration increased
heart rate, mean aortic pressure, first derivative of left ventricular
pressure, cardiac output and myocardial contractility in pacing-
induc= congestive heart failure . These changes correlated signif.
icantly with basal plasma beta-endorphin levels and were accom.
panied by increases in plasma beta-endorphin and catecholantines
after natoxone administration . However, unlike the hemodynarnie
and cardiac effects of naloxone, baroreflex function did not change
after naloxone in dogs with congestive heart failure .
Conclusions. The increase in basal plasma beta-endorphin
suggests that the endogenous opiate system is activated in left-
sided congestive heart failure. Because naloxone improves the
systemic hemodynamics and myocardial contractile function un-
der this condition, the endogenous opiaids appear to play an
important role in mediating the myocardial depression that occurs
in heart failure . However, the endogenous opiate system has no
apparent effect on the regulation of barorellex control in heart
failure induced by rapid pacing .
(,f Am Coll Cordial 1994;23:194-200)
cardiac function and systemic arterial pressure . We have
also found (10) in the same model of heart failure that
naloxone improved the impaired arterial baroreceptor sensi-
tivity. These findings suggest that the endogenous opiate
system may contribute to the cardiovascular depression and
reduced baroreflex function that occur in heart failure .
Although plasma beta-endorphin levels have been shown
to be elevated in patients with left-sided congestive heart
failure, reflecting the severity of the disease (11), naloxone
administration produced no hemodynamic improvements in
a study (12) involving six patients with heart failure who had
greatly reduced left ventricular ejection fractions and ele-
vated pulmonary artery wedge pressures . The etiology of
heart failure was idiopathic dilated cardiomyopathy in four
of these patients and ischemic cardiomyopathy in the other
two. The investigators (12) suggested that the discrepancies
between their study in humans and our findings in dogs with
right heart failure might be related to the different types of
heart failure studied . To ensure that our prior findings of
naloxone are not unique to right-sided failure, we carried out
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the present study in dogs with rapid pacing-induced biven-
tricular congestive heart failure, which exhibits many of the
hemodynamic and neurohumoral changes seen in dilated
cardiomyopathy in humans (13-15) .
Methods
Surgical preparation . Congestive heart failure was pro-
duced by chronic rapid right ventricular pacing in adult
mongrel dogs weighing 18 .6 to 30,5 kg . The animals were
anesthetized with sodium pentobarbital (25 mg/kg body
weight intravenously) and ventilated with room air with use
of a Harvard respirator . A left thoracotomy was performed
through the fifth intercostal space under sterile conditions .
the pericardial sac opened, and heparin-filled Tygon cathe-
ters (inner diameter 1 .02 rain, Norton Co., Plastics & Syn-
thetics Division) were then inserted into the left atrium, main
pulmonary artery and the descending thoracic aorta. A
Konigsberg micromanorneter was placed in the left ventricle
through a stab wound at the apex, All catheters were exterior-
ized to the back of the neck, and the chest was closed . After
recovery from the surgical 7rocedure for I week, and under
sterile conditions and pentobarbital general anesthesia, a
custom-designed Medtronic multiprogrammable pulse gen-
erator was placed in a cervical pocket and connected to a
bipolar transvenous ventricular pacing lead that was inserted
into an external jugular vein and positioned at the apex of the
right ventricle . Dogs were randomly assigned to undergo
either rapid ventricular pacing (rate 225 beats/min) or control
pacing (rate 100 beats/min) . Pacing was maintained through-
out the study period as verified by weekly electrocardio-
graphic (ECG) and hemodynamic recordings . All dogs were
closely monitored for the development o1 respiratory dis-
tress, ascites, anoxia and elevated left atrial pressure . Final
hemodynamic and barore ex studies were performed after
8 weeks of pacing .
The study was approved by the University of Rochester
Committee on Animal Resources and conformed to the
guiding principles approved by the Council of the American
Physiological Society and the National Institutes of Health
guide on the humane care and use of laboratory animals .
Measurements and protocol . Studies were performed in
I I dogs with control pacing and 15 dogs with congestive
heart failure induced by rapid ventr ; 'ilar pacing. Dogs were
trained to lie quietly in a lateral decubitus position on an
experimental table with minimal restrictions, and none of the
animals received premeditation . To measure the baseline
unpaced heart rate, the pacemaker was reprogrammed to a
subthreshold level at least 2 h before experimental studies
were performed
. Atraumatic ECG electrodes
were attached
to the limbs for measuring RR intervals. The previously
implanted catheters were connected to Statham P23Db pres-
sure transducers and a multichannel Brush model 480 re-
corder (Gould Inc ., Instrument Systems Division) for mea-
suring pressures . Left ventricular pressure was obtained
from the Konigsberg micromanometer, which was calibrated
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against the aortic and left atrial pressure measurements,
Zero pressure was set at the midthoracic level . The first
derivative of left ventricular pressure (dPldt) was measured
with an electronic differentiator . Cardiac output was deter-
mir9ed by injecting indocyanine green (Cardio-Green, yn-
son, Westcott & Dunning, Inc .) into the pulmonary artery
and sampling arterial blood for the dye concentration with a
Honeywell model D-014 cardiac output computer (Lyons
Medical Electronics Corp .) .
All dogs were studied twice, at least 2 days apart, with
either normal saline solution or naloxone hydrochloride
(1 .0 mg/kg body weight ; Sigma Chemical) dissolved in 10 ml
of normal saline solution . The order of normal saline solution
and naloxone administrations was randomized . After base-
line systemic hemodynamic measurements were obtained in
triplicate over a 15-min baseline period, normal saline solu-
tion or naloxone was intravenously infused slowly over
3 min. Heart rate, aortic pressure, left ventricular dPldt,
cardiac output and left atrial pressure were measured at
5-min intervals for 20 min after the administration of saline
solution or naloxone . The averages of these measurements
were used for statistical analyses . Blood samples for beta-
endorphin and catecholamines were obtained during the
baseline period and again at 15 min after each infusion .
Plasma beta-endorphin was determined by radioimmuno-
assay (16) after extraction on an SP-Sephadex C-25 column
with reagents purchased from Immuno Nuclear Corp .
Plasma catecholamines were measured by a radioenzymatic
method using catechol-®-methyltransferase (17) .
The effects of naloxone and normal saline solution on
haroreflex sensitivity and intrinsic myocardial contractility
were evaluated in eight control dogs and nine dogs with
pacing-induced congestive heart failure . Baroreflex sensitiv-
ity was determined from the slope of a regression line
relating RR interval to systolic pressure while the blood
pressure was increasing in response to intravenous bolus
injection of phenylephrine hydrochloride (18) . At the same
time, echocardiographic end-systolic cross-sectional areas
were obtained from a Toshiba SSH-60A echocardiograph
and plotted against their respective peak systolic aortic
pressure . The slope of pressure-area relation (Emax) was
taken as an index of intrinsic myocardial contractility
(19,20). The measurements were based on values obtained
during the initial increase in blood pressure occurring within
the l st 15 s after phenylephrine injection . These procedures
were performed during the baseline studies and again 30 min
after infusion of normal saline solution or naloxone-
At the end of each study, intravenous fentanyl (0 .2 mg), a
mil-receptor agonist (21), was administered to confirm phar-
macologic opiate receptor blockade produced by naloxone
.
Statistical analyses . The experimental data were analyzed
statistically using the RS/l system developed by BBN Soft-
ware Products Corp. on an IBM personal computer
. Results
are presented as mean value ± SE . The statistical signifi-
cance of differences between the control dogs and the dogs
with congestive heart failure was determined by the Student
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Table 1 . Baseline Hemodynamic Variables in Control Dogs and
Dogs With Congestive Heart Failure
*p < 0.01 compared with value in control dogs, as determined by Student
i test for unpaired data
. Values shown are mean value ± SE. CHF =
congestive heart failure ; LV = left ventricular
: LV dPldt = first derivative of
left ventricular pressure .
t test for unpaired data, whereas the difference between 2
means within the same group was analyzed by the Student t
test for paired data. However, when data involved repeated
measures in the control and heart failure groups, two-way
analysis of variance (ANOVA) was used to determine the
statistical significance of difference in responses between the
groups, differences between the effects of naloxone and
normal saline solution, and interactions between the two
independent variables (groups and drug interventions) for
each of the responses . Significant differences were deter-
mined using Bonferroni simultaneous confidence intervals
for all comparisons . The relations between two variables
were determined by correlation and regression analyses .
Only those lines of linear regression with r > 0 .85 were used
for measuring baroreflex sensliivity index and Emax . A
p value < 0.05 was considered statistically significant .
Results
Opiate receptor inhibition by oxoste. Naloxone pro-
duced significant opiate receptor inhibition, as evidenced by
the marked diminution of the decrease in mean aortic
pressure occurring after intravenous fentanyl administration
(3 ± 1 vs. 22 ± 2 mm Hg, p < 0 .001). Furthermore, because
this effect was present 30 min after naloxone administration,
the receptor blocking action of naloxone persisted through-
out the hemodynamic and baroreflex studies that were
performed within the 1st 30 min after naloxone administra-
tion .
Systemichemodynamics . Table I shows the baseline hemo-
dynamic characteristics in control dogs and dogs with pac-
ing-induced congestive heart failure
. At baseline, dogs with
heart failure exhibited higher values for heart rate, mean
pulmonary artery blood pressure, left atrial pressure and left
ventricular end-diastolic pressure than did the control group .
In contrast, mean aortic pressure, left ventricular dP/dt and
cardiac output were lower in this group .
The dogs with congestive heart failure responded to
naloxone with an immediate progressive increase in aortic
Control GHF Control CHF
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Figure 1 . Changes from baseline of heart rate, mean aortic blood
pressure (BP), first derivative of left ventricular pressure (LV dP/dt)
and cardiac output produced by naloxone and normal saline solution
in control dogs and dogs with congestive heart failure (CHF) .
Analysis of variance showed significant differences between the
groups for the responses of heart rate (F = 11 .44, p < 0 .001), mean
aortic pressure (F = 27 .94, p < 0.001), left ventricular dP/dt (F
21 .18, p < 0 .001) and cardiac output (F = 5 .77, p < 0.003) . Multiple
comparison tests were used to determine the statistical significance
of differences between the means . *p < 0.05 compared with saline
solution . fp < 0.05 compared with corresponding values in control
dogs,
pressure at,d left ventricular dP/dt. Because the effects
reached a steady state between 5 and 20 min after naloxone
administration, the four repetitive measurements obtained
during that interval were averaged . The averages were then
subtracted from the baseline value and the differences used
to determine the statistical significance of changes produced
by naloxone and normal saline solution. Figure 1 shows that
naloxone caused significant increases in heart rate, mean
aortic blood pressure, left ventricular dP/dt and cardiac
output in dogs with congestive heart failure . Two-way
ANOVA and multiple comparison tests showed significant
differences in the hemodynamic responses between the
groups and between the saline and naloxone administrations .
There was also a significant statistical interaction between
the two independent factors (groups and drug interventions)
for the responses of heart rate (F = 16 .27, p < 0 .001), mean
aortic pressure (F = 21 .89, p < 0.001) and left ventricular
dP/dt (F = 19.50, p < 0.001). However, the interaction
between the group and drug factors did not differ signifi-
cantly for the cardiac output response (F = 1 .79, p = 0.19) .
Furthermore, neither left atrial pressure (26 ± 2 to 28
2 mm Hg) nor left ventricular end-diastolic pressure (31 ± 2
to 32 ± 2 mm Hg) changed significantly . Administration of
normal saline solution produced no significant changes in the
heart failure or control group .
Plasma beta-endorphin and catecholamines. Baseline
plasma beta-endorphin, norepinephrine and epinephrine lev-
els were significantly higher in dogs with pacing-induced
Control
Dogs
(n = II)
Dogs
With CHF
(n = 15)
Heart rate (beatslmin) 103 ± 5
138 *_ 6*
Mean aortic pressure (mm Hg)
±2 97 ± 2*
Mean pulmonary pressure (mm Hg) 19+1 33 ± 2*
Left atriai pressure (mm Hg) 8±1 26 ± 2*
LV ervtediaslolic pressure (mm Hg) 10 t1 31 ± 2*
LV dPIdt (mm Hgls) 2.833 ± 123 1,488 t 5I*
Cardiac output (liters/min) 4 .50 ± 0 .29 2 .52 ± 0 .16*
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plasma beta-endorphin . norc.pinephrine
and epinephrine in dogs with congestive heart failure (CHF) and in
control dogs . *p < 0.05 compared with control values by Student t
test for unpaired data. pM = picamoles per liter.
congestive heart failure than in - -.-)ntrol dogs (Fig . 2) . Nalox-
one administration produced further increases in plasma
beta-endorphin, norepinephrine and epinephrine levels in
the group with heart failure but had no significant effects in
control dogs (Fig . 3). Normal saline solution did not affect
any of the hormone levels is either group. Statistically
significant interactions existed between the group and drug
factors for the norepinephrinc (F = 11 .37, p = 0 .002) and
epinephrine (F = 11 .26, p = 0.002) responses in the two-way
ANOVA.
Correlation between plasma beta-endorphin and hemadly-
namic changes . Figure 4 shows that the baseline plasma
beta-endorphin levels correlated significantly with the in-
creases in mean aortic pressure, left ventricular dP/dt and
cardiac output that occurred after naloxone administration in
the dogs with congestive heart failure .
Myocardial contractility and barareflex sensitivity. Phe-
nylephrine produced an acute transient increase in aortic
pressure. The dose of phenylephrine needed to produce the
target increase in aortic pressure (25 to 30 mm Hg) was much
higher in the dogs with congestive heart failure (d8
T
4 jQg) than in the control group (6 ± I pglkg, p < 0 .001) .
However, the dose of phenylephrine given to each animal
before and after naloxone administration was the same . A
significant correlation (r > 0.85) was found between systolic
aortic pressure and end-systolic area, and between systolic
aortic pressure and RR interval . Table 2 shows that Emax
was lower in the dogs with heart failure than in the control
24
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Fig-ire 3 . Changes in plasma beta-endorphin, norepinephrine and
epinephrine after administration of normal saline solution and nab
ozone in dogs with congestive heart failure and control dogs .
Analysis of variance showed significant differences between the
groups for the responses of beta-endorphin (F = 7 .62, p < 0 .001),
norepinephrine (F = 9 .37 .p < 0 .001) and epinephrine (F = 9 .98, p <
0.01) . Multiple comparison tests were used to determine the
statistical significance of differences between the means . *p < 0.05
compared values in dogs given saline s olution . t p < 0.05 compared
with corresponding values in control dogs. Abbreviations as in
Figure 2,
group, and that naloxone administration increased Emax in
the heart failure group . In contrast, naloxone produced no
significant effect on Emaxx in control dogs . Baroreflex sensi-
tivity index was also lower in the heart failure than in the
control group, but it was unaffected by naloxone (Table 2) .
Normal saline solution had no effect on Etnax or baroreflex
sensitivity index in either group .
Discussion
Hemodysiantle and neurehormonall profiles . Our present
study shows that chronic rapid ventricular pacing resulted in
significant congestive heart failure, as manifested
by a high
heart rate, elevated left ventricular filling pressure and a low
aortic pressure, left ventricular dP/dt, cardiac output and
Emax. In addition, circulating beta-endorphin and cate-
cholamines increased
. These hemodynamic and neurohu-
moral changes are similar to those that occur in patients with
congestive heart failure .
Two serial studies with administration of either naloxone
or normal saline solution were performed several days apart
in the present study . The baseline hemodynamic and neuro-
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Figure 4
. Correlation between baseline plasma beta-endorphin val-
ues and changes in mean aortic blood pressure (EP)
. first derivative
of left ventricular pressure (LV dPidt) and cardiac output produced
by naloxone in 15 dogs with congestive heart failure
.
humoral variables were similar on the two occasions, indi-
cating no significant changes in the heart failure state be-
tween the 2 days. Administration of naloxone increased
heart rate, mean aortic pressure, left ventricular dPldt and
cardiac output in the dogs with congestive heart failure .
Because left ventricular dP/dt is load-dependent (22), we also
utilized echocardiography to measure the systolic pressure-
area relation (Emax), which has been shown to be sensitive
to the changes in myocardial contractile function but insen-
Table 2. Myocardial Contractility Index and Baroreflex Sensitivity
in Control Dogs and Dogs With Congestive Heart Failure
Myocardial Contractility
Index (pmax) Baroreflex Sensitivity
(mm Hglcm 2) ( ms/mm Hg)
Dogs With Dogs With
Control Dogs CHF Control Dogs CHF
*p < 0.001 compared with corresponding values in control dogs . t p <
0.001 compared with the respective baseline value . Values shown are mean
value *_ SE. CHF = congestive heart failure .
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sitive to load . The Ernax measurements were based on
values obtained during the 1st 15 s after phenylephrinc
injection, presumably before the reflex changes could have
occurred to alter the myocardial contractile function . The
linearity of the end-systolic pressure-area relation also sug-
gests that contractile function did not change much during
the pressure loading. Our findings that Emax increased after
administration of naloxone in congestive heart failure are
consistent with the increase in intrinsic myocardial contrac-
tility induced by naloxone . These systemic hemodynamic
and left ventricular dPldt changes produced by naloxone in
dogs with pacing-induced heart failure were similar to our
previous findings in dogs with chronic right-sided heart
failure (8,9) . Thus, opiate receptor inhibition lessens the
cardiac depression that occurs in congestive heart failure
irrespective of the ventricular site involved . Furthermore,
because the changes in mean aortic pressure, left ventricular
dPldt and cardiac output induced by naloxone significantly
correlated with the baseline plasma beta-endorphin levels,
the hemodynamic responses to naloxone were influenced by
the degree of activation of the endogenous opiate system .
These findings further support the concept that naloxone
exerts its effects by inhibiting the actions of the endogenous
opiate system in congestive heart failure .
Naloxone produced no significant changes in plasma
beta-endorphin or catecholamines in normal animals. The
hemodynatnic effects of naloxone in control dogs were also
small . These findings are consistent with results of studies in
normal human subjects (23,24), probably because the endo-
genous opiate system is normally quiescent and no apparent
effect is expected after its inhibition .
In addition to the elevated basal plasma beta-endorphin in
congestive heart failure, naloxone administration caused a
further increase in plasma beta-endorphin levels. These
findings are consistent with the view that the endogenous
opiarze system is activated in congestive heart failure and that
naloxone enhances secretions of beta-endorphin when the
negative feedback control of beta-endorphin release is inhib-
ited by the opiate antagonist (25,26) . Naloxone is also
expected to disinhibit the sympathetic nervous system and
to increase plasma catecholamines (25,27) as demonstrated
in our present study . Plasma norepinephrine also increases
after naloxone administration in the conscious rabbit with
hemorrhagic hypotension (28). Naloxonc probably exerts its
hemodynamic effects by inhibiting the delta-receptor-
mediated effects within the central nervous system that
decreases the sympathetic nervous system activity (unpub-
lished observations). However, a direct effect of naloxone
on the heart cannot be excluded, because naloxone has been
shown to increase the contractile force of isolated papillary
muscle (29) . Naloxone also has been shown to enhance
regional myocardial contractile performance after low-dose
intracoronary injection (30) . Specific opiate receptor ago-
nists have been shown to cause a negative inotropic action
on isolated adult rat ventricular myocytes, suggesting there
are functioning delta- and kappa-receptors (31) . Addition-
(n=8) (n=9) (n=8) (n=9)
Condition A
Baseline 21 .4±1 .2 10.5±1 .2* 21 .5±0 .9 11 .0±1 .1*
Naloxone 21 .7± 1 .4 12 .4= 1 .0*t 22.3± 1 .3 9.6±0.9*
Condition B
Baseline 21 .9 ± 1 .1 10 .4*_1 .2* 22.2±1 .0 10 .7 ± 1 .9*
Saline solution 21 .7 ± 1 .2 10 .1 ± 1 .0* 23 .1 ± 1 .1 11 .0}2.0*
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ally, because there are presynaptic opiate receptors that
inhibit the local release of neurotransmitter (32,33), naleox-
one may improve myocardial contractility by facilitating the
release of local norepinephrine .
Our present study differs from that of Kindmar and
Fowler (12), who found no hemodynamic effects of naloxone
in patients with ischemic and idiopathic cardiomyopathies .
The reason for the discrepancies cannot be stated with
certainty . However, because the prior study was performed
in only six patients with mild to moderate symptomatic
congestive heart failure and provided no documentation of
elevated endogenous opioid levels, the lack of effects of
naloxone could have been related to the small sample size or
to no or little endogenous opiate system activation in the
human study, or both .
Baroreflex sensitivity, baroreflex sensitivity was reduced
in dogs with pacing-induced congestive heart failure . Similar
changes have been observed in congestive heart failure of
different etiologies (10,34®36). Our laboratory (10) was the
first to describe the contribution of the activated endogenous
opiate system to depressed baroreflex sensitivity in right-
sided congestive heart failure . We attribute this effect of
naloxone to removal of a mu-receptor-mediated inhibitory
action within the central nervous system (10). However, in
the present study, naloxone did not restore the blunted
baroreflex sensitivity index in dogs with pacing induced
heart failure . The reasons for the discrepancies between the
right-sided congestive heart failure and the pacing-induced
biventricular congestive heart failure may be related to some
physiologic differences between two experimental models of
heart failure . First, the dogs with pacing-induced congestive
heart failure differ from animals with right-sided congestive
heart failure in that left ventricular filling pressure was
elevated only in the former group . Elevated left ventricular
filling pressure is known to depress baroreceptor function
(37,38). Second, the doses of phenylephrine to produce the
same increment of aortic pressure were much larger in dogs
with pacing-induced failure than in dogs with right-sided
failure, suggesting a reduction of arterial contractile respon-
siveness in pacing-induced congestive heart failure . Thus, in
this model of heart failure, afferent abnormalities from the
low pressure cardiac chamber or arterial baroreceptors
might have masked the potential central effects of naloxone
on baroreflex sensitivity that we observed in dogs with
right-sided heart failure . We (39) recently observed that
nitroprusside infusion reduced left atrial pressure and in-
creased the baroreflex sensitivity index in the dogs with
pacing-induced heart failure . The inverse correlation be-
tween left atrial pressure and baroreflex sensitivity index
suggests that the improvement in baroreflex sensitivity pro-
duced by naloxone could have been offset by the increased
left ventricular filling pressure as the ventricular afterioad
increased .
Conclusions . The present study provides further support
of the salutary effect of naloxone on cardiovascular system
in congestive heart failure . In addition, the hemodynamic
HIMIJRA ET AL
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changes produced by naloxone correlate to the degree of
endogenous opiate system activation and ,may be . partly
mediated by a further increase in sympathetic outflows,
unlike the systemic hemodynamic response, the blunted
arterial baroreflex sensitivity was not improved by naloxone
in this trodel, suggesting that the endogenous opiate system
has little contribution in impairing baroreflex function in
dogs with pacing-induced congestive heart failure .
We thank Sherry Steinmetz, Helen E lam and Amy M
. Mohan for excellent
technical assistance .
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